Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Tezspire

Tezspire

(tezepelumab) subcutaneous injection

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 7 Apr, 2022
Vitalii Mazuryk profile picture
Vitalii Mazuryk
edited on 7 Apr, 2022
Edits made to:
Description (+36 characters)
Article (+320 characters)
Topic thumbnail

Tezspire

(tezepelumab) subcutaneous injection

Article

TEZSPIRE is for people aged 12 and up with severe asthma who are taking medium- to high-dose inhaled corticosteroids and at least one other controller medication.

If you have severe asthma that is uncontrolled, TEZSPIRE could help you experience better breathing in as little as 2 weeks.

TEZSPIRE is not a rescue medicine.

"Edit from table cell"
Vitalii Mazuryk profile picture
Vitalii Mazuryk
edited on 7 Apr, 2022
Edits made to:
Infobox (+2 properties)
Infobox
Industry
Pharmaceutical industry
Pharmaceutical industry
Product parent company
Amgen
Amgen
"Created via: Web app"
Vitalii Mazuryk profile picture
Vitalii Mazuryk
created this topic on 7 Apr, 2022
Edits made to:
Infobox (+2 properties)
Topic thumbnail

 Tezspire

(tezepelumab) subcutaneous injection

Infobox
Is a
Product
Product
Website
https://www.tezspire.com

Find more entities like Tezspire

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.